CAC
HOLX

Cowen and Company’s Hologic HOLX Stock Holding History

Cowen and Company’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-534
Closed -$37.1K – 628
2023
Q3 		$37.1K Buy
+534
New +$40.4K ﹤0.01% 313
2022
Q4 		– Sell
-3,528
Closed -$228K – 704
2022
Q3 		$228K Buy
+3,528
New +$244K 0.02% 171
2022
Q2 		– Sell
-3,622
Closed -$278K – 686
2022
Q1 		$278K Buy
+3,622
New +$260K 0.03% 204

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cowen and Company's HOLX Position: Q4 2023 in Review

Cowen and Company sold out of Hologic (HOLX) in Q4 2023, closing a stake of 534 shares — an estimated $37.1K sold.

Cowen and Company first reported a position in HOLX in Q1 2022 and held it in 3 quarters. The position peaked at $278K in Q1 2022. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Cowen and Company reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Cowen and Company sold 534 Hologic shares in Q4 2023, an estimated $37.1K.
  • Cowen and Company first reported a position in Hologic in Q1 2022 and held it in 3 quarters.
  • Cowen and Company's Hologic position peaked at $278K in Q1 2022.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.